HARVEY S. SADOW, PH.D

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Anika Therapeutics, Inc.

Filing Date Source Excerpt
2001-04-30 During 2000, each director who was not an employee of the Company was entitled to receive a director's fee of $10,000 and immediately exercisable options for 1,596 shares of Common Stock under the Stock Option Plan. The number of stock options granted was valued at approximately $10,000 using the Black-Scholes method.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22